GlassScriptPhysician profile
Anitha Nimma
NPI 1194189209
$1,527.86
in general payments reported to CMS, 2019-2025
19 companies · $640 in 2025
The $640 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.00 · 2020: $164 · 2021: $28.88 · 2022: $212 · 2023: $193 · 2024: $275 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.69 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $764.90 | 2021-2025 | |
| Genentech USA, INC. | $120.85 | 2020 | |
| Janssen Biotech, INC. | $104.99 | 2025 | |
| Boston Scientific Corporation | $104.05 | 2024-2025 | General - Dbs |
| Medtronic, INC. | $88.55 | 2024 | Percept PC Brainsense |
| Argenx US, INC. | $54.31 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Biogen, INC. | $42.90 | 2020-2025 | Tysabri |
| Pfizer INC. | $35.02 | 2025 | |
| Globus Medical, INC. | $34.89 | 2025 | Senza |
| Ucb, INC. | $29.01 | 2020 | |
| Grifols USA, LLC | $21.64 | 2025 | Gamunex-C |
| Eisai INC. | $19.00 | 2025 | |
| Otter Pharmaceuticals, LLC | $16.78 | 2025 | Sympazan |
| Teva Pharmaceuticals USA, INC. | $16.77 | 2025 | Austedo Xr |
| Sk Life Science, INC. | $16.49 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.99 | 2022 | |
| Genentech, INC. | $15.00 | 2019 | |
| Amneal Pharmaceuticals LLC | $13.80 | 2023 | Rytary |
| Biohaven Pharmaceutical Holding Company LTD. | $12.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anitha Nimma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.